KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Common Equity (2016 - 2025)

Historic Common Equity for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $23.9 billion.

  • Eli Lilly's Common Equity rose 6654.77% to $23.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $23.9 billion, marking a year-over-year increase of 6654.77%. This contributed to the annual value of $14.3 billion for FY2024, which is 3136.96% up from last year.
  • According to the latest figures from Q3 2025, Eli Lilly's Common Equity is $23.9 billion, which was up 6654.77% from $18.3 billion recorded in Q2 2025.
  • Eli Lilly's Common Equity's 5-year high stood at $23.9 billion during Q3 2025, with a 5-year trough of $6.7 billion in Q2 2021.
  • Moreover, its 5-year median value for Common Equity was $11.1 billion (2023), whereas its average is $12.0 billion.
  • Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 12204.74% in 2021, then soared by 81.95% in 2023.
  • Quarter analysis of 5 years shows Eli Lilly's Common Equity stood at $9.2 billion in 2021, then rose by 17.7% to $10.8 billion in 2022, then increased by 0.82% to $10.9 billion in 2023, then surged by 31.37% to $14.3 billion in 2024, then surged by 67.12% to $23.9 billion in 2025.
  • Its last three reported values are $23.9 billion in Q3 2025, $18.3 billion for Q2 2025, and $15.8 billion during Q1 2025.